Carcinogenicity and testicular toxicity of 2-bromopropane in a 26-week inhalation study using the rasH2 mouse model

[1]  H. Senoh,et al.  No evidence for carcinogenicity of titanium dioxide nanoparticles in 26-week inhalation study in rasH2 mouse model , 2022, Scientific Reports.

[2]  Y. Furukawa,et al.  Dose–response relationship of pulmonary disorders by inhalation exposure to cross-linked water-soluble acrylic acid polymers in F344 rats , 2022, Particle and fibre toxicology.

[3]  H. Senoh,et al.  Pulmonary dust foci as rat pneumoconiosis lesion induced by titanium dioxide nanoparticles in 13-week inhalation study , 2022, Particle and Fibre Toxicology.

[4]  R. Takahashi,et al.  rasH2 mouse: reproducibility and stability of carcinogenicity due to a standardized production and monitoring system , 2021, Journal of toxicologic pathology.

[5]  R. Young,et al.  28‐Day somatic gene mutation study of 1‐bromopropane in female Big Blue® B6C3F1 mice via whole‐body inhalation: Support for a carcinogenic threshold , 2019, Regulatory toxicology and pharmacology : RTP.

[6]  Test No. 412: Subacute Inhalation Toxicity: 28-Day Study , 2018, OECD Guidelines for the Testing of Chemicals, Section 4.

[7]  K. Straif,et al.  Carcinogenicity of some industrial chemicals. , 2016, The Lancet Oncology.

[8]  Ivan Rusyn,et al.  Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.

[9]  Toxicology and carcinogenesis studies of 1-bromopropane (CAS No. 106-94-5) in F344/N rats and B6C3F1 mice (inhalation studies). , 2011, National Toxicology Program technical report series.

[10]  M. Pino,et al.  Proliferative and Nonproliferative Lesions of the Rat and Mouse Respiratory Tract , 2009, Toxicologic pathology.

[11]  H. Ahn,et al.  An age‐adjusted bootstrap‐based Poly‐k test , 2005, Statistics in medicine.

[12]  T. Nohmi,et al.  Molecular nature of intrachromosomal deletions and base substitutions induced by environmental mutagens , 2005, Environmental and molecular mutagenesis.

[13]  Sung-Ho Kim,et al.  Effects of prenatal exposure to the environmental pollutant 2-bromopropane on embryo-fetal development in rats. , 2004, Toxicology.

[14]  J. French,et al.  The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  R. Grundmann.  The Montreal protocol , 2003 .

[16]  C. Alden,et al.  The Tg rasH2 Mouse in Cancer Hazard Identification , 2002, Toxicologic pathology.

[17]  N. Hisanaga,et al.  Involvement of Bcl-2 family genes and Fas signaling system in primary and secondary male germ cell apoptosis induced by 2-bromopropane in rat. , 2001, Toxicology and applied pharmacology.

[18]  K. Kang,et al.  2-Bromopropane induced germ cell apoptosis during spermatogenesis in male rat. , 2001, The Journal of veterinary medical science.

[19]  S. Cohen,et al.  Alternative Models for Carcinogenicity Testing: Weight of Evidence Evaluations Across Models , 2001, Toxicologic pathology.

[20]  T. Nohmi,et al.  Recent advances in the protocols of transgenic mouse mutation assays. , 2000, Mutation research.

[21]  M. Suda,et al.  Influence of 2-bromopropane on reproductive system—Short-term administration of 2-bromopropane inhibits ovulation in F344 rats , 2000, Toxicology and industrial health.

[22]  I. Chahoud,et al.  Male reproductive toxicity and b-luteinizing hormone gene expression in sexually mature and immature rats exposed to 2-bromopropane , 1999, Human & experimental toxicology.

[23]  N. Hisanaga,et al.  2-Bromopropane causes ovarian dysfunction by damaging primordial follicles and their oocytes in female rats. , 1999, Toxicology and applied pharmacology.

[24]  B. Kang,et al.  Effects of 2-bromopropane on spermatogenesis in the Sprague-Dawley rat. , 1999, Reproductive toxicology.

[25]  M. Kamijima,et al.  Occupational health survey on workers exposed to 2-bromopropane at low concentrations. , 1999, American journal of industrial medicine.

[26]  N. Inoue,et al.  Histopathological evidence that spermatogonia are the target cells of 2-bromopropane. , 1998, Toxicology letters.

[27]  T. Honma,et al.  Influence of 2-bromopropane on reproductive system--2-bromopropane inhibits forced ovulation in mice. , 1998, Industrial Health.

[28]  Y Kurokawa,et al.  Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. , 1998, Environmental health perspectives.

[29]  Kim Hy,et al.  Reproductive toxicity of 2-bromopropane in Sprague Dawley rats , 1997 .

[30]  N. Inoue,et al.  Histopathological Changes of the Testis in Rats Caused by Subcutaneous Injection of 2‐Bromopropane , 1997 .

[31]  M. Kamijima,et al.  2‐Bromopropane‐Induced Hypoplasia of Bone Marrow in Male Rats , 1997 .

[32]  M. Kamijima,et al.  A Review on Toxicity of 2‐Bromopropane: Mainly on its Reproductive Toxicity , 1997 .

[33]  N. Hisanaga,et al.  Ovarian Toxicity of 2‐Bromopropane in the Non‐Pregnant Female Rat , 1997 .

[34]  Jungsu Park,et al.  An Outbreak of Hematopoietic and Reproductive Disorders Due to Solvents Containing 2‐Bromopropane in an Electronic Factory, South Korea: Epidemiological Survey , 1997 .

[35]  M. Kamijima,et al.  Histopathologic Findings of Bone Marrow Induced by 2‐Bromopropane in Male Rats , 1997 .

[36]  I. Yu,et al.  Effects of 2-bromopropane on the female reproductive function in Sprague-Dawley rats. , 1997, Industrial health.

[37]  N. Hisanaga,et al.  Testicular and Hematopoietic Toxicity of 2‐Bromopropane, a Substitute for Ozone Layer‐Depleting Chlorofluorocarbons , 1997 .

[38]  N. Hisanaga,et al.  Disruption in Ovarian Cyclicity Due to 2‐Bromopropane in the Rat , 1997 .

[39]  N. Inoue,et al.  Toxicity of 2‐Bromopropane on Spermatogonia and Spermatocyte , 1997 .

[40]  I. Yu,et al.  Reproductive toxicity of 2-bromopropane in Sprague Dawley rats. , 1997, Scandinavian Journal of Work, Environment and Health.

[41]  I. Yu,et al.  Mutagenicity of 2-bromopropane. , 1997, Industrial health.

[42]  S. Wakana,et al.  Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. , 1996, Carcinogenesis.

[43]  N. Hisanaga,et al.  Testicular Toxicity of 2‐Bromopropane , 1996 .

[44]  Y. Moon,et al.  Hematopoietic and reproductive hazards of Korean electronic workers exposed to solvents containing 2-bromopropane. , 1996, Scandinavian journal of work, environment & health.

[45]  O. Ueda,et al.  Other transgenic mutation assays: A new transgenic mouse mutagenesis test system using Spi− and 6‐thioguanine selections , 1996, Environmental and molecular mutagenesis.

[46]  J. Foliguet.  (a) An Epidemiological Survey , 1956, Revue d'hygiene et de medecine sociale.